Osso VR’s surgical training technology provides on-demand, educational experiences that are effective, repeatable, and measurable to help surgeons reach proficiency with emerging surgical techniques and technologies.
Osso VR’s technology is being used by more than 20 leading teaching hospitals and eight top medical device companies in 20 countries and has been shown to improve surgical performance by 230% in a peer-reviewed study in the Journal of Surgical Education.
This funding will enable RetiSpec to accelerate the commercialization of its groundbreaking technology aimed at early detection of Alzheimer's disease.
